Clinical Outcomes of Percutaneous Nephrolithotomy Following Retrograde Percutaneous Nephrostomy Access Using Novel Device in Comparison to Antegrade Access - Trial NCT05022537
Access comprehensive clinical trial information for NCT05022537 through Pure Global AI's free database. This phase not specified trial is sponsored by The University of Texas Health Science Center, Houston and is currently Not yet recruiting. The study focuses on Kidney Stone. Target enrollment is 50 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
The University of Texas Health Science Center, Houston
Timeline & Enrollment
N/A
Sep 01, 2021
Dec 01, 2023
Primary Outcome
Treatment efficacy as measured by the time taken from diagnosis to nephrostomy access,Treatment efficacy as measured by total time of access operation.,Treatment efficacy as measured by total time of access operation fluoroscopy,Treatment efficacy as measured by total time of lithotomy operation,Treatment efficacy as measured by total time of lithotomy operation fluoroscopy,Treatment efficacy as measured by length of post-operative hospital stay,Number of patients that are stone free,Number of patients with symptom free survival as defined as lack of flank pain,Number of patients with symptom free survival as defined as lack of presence of urinary or gastrointestinal symptoms,,Number of patients with symptom free survival as defined as lack of limitations to work,Number of patients with symptom free survival as defined as lack of limitations to social or daily activities.
Summary
The purpose of this study is to compare relevant clinical outcomes in patients requiring
 percutaneous nephrostomy for urolithiasis treatment between those who undergo an antegrade
 approach versus a retrograde approach and to determine which clinical characteristics predict
 success of lithotomy with anterograde or retrograde percutaneous nephrostomy approaches.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05022537
Device Trial